CD4 and neoplasm: As mentioned before, immune function is generally compromised in cancer patients, which have lower absolute numbers of peripheral blood lymphocytes but increased numbers of functionally suppressive CD4+CD25+ Treg and dysfunctional dendritic cells (DC) in peripheral blood and tumor microenvironment [24].